Duorui Pharmaceutical Borrows 280 Million Yuan from Former Controlling Shareholder to Replenish Working Capital

Corporate Action
โดย 财中社·Read original
Summary · why it matters

Duorui Pharmaceutical announced that the company has borrowed 280 million yuan from its former controlling shareholder, Tibet Jiakang Times Technology Development Co., Ltd., to replenish working capital. The loan term is 12 months, with interest calculated at the one-year Loan Prime Rate, and principal plus interest will be repaid in a lump sum upon maturity. Tibet Jiakang still holds an 11.16% stake in the company, making it a related legal entity, and this transaction constitutes a related-party transaction. In the first quarter of 2026, Duorui Pharmaceutical achieved revenue of 32.43 million yuan and a net loss attributable to the parent company of 13.97 million yuan.

Impact on stocks 1

Others▼ · 1 stocks

Off-coverage companies 1

西藏嘉康时代科技发展有限公司 (Tibet Jiakang Times Technology Development Co., Ltd.)Private± Mixed
Capitalrelevance

As the lender in a related-party transaction, the loan provides interest income but also reflects the borrower's financial weakness.

© 2026 MarketDXNews